Kirkia wilmsii
Kirkia wilmsii · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Kirkia wilmsii is a botanical species that has garnered scientific interest due to its diverse medicinal potential. Research has focused on evaluating the plant's bioactive properties, specifically its antifungal and antimicrobial activities. Studies utilizing various preparations, including crude leaf and twig extracts as well as specific fraction 5 of the twig extract, have demonstrated significant biological effects. These preparations have shown effectiveness against challenging pathogens such as Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, and Enterococcus faecalis. Consequently, the leaf and twig components of this plant represent promising sources for developing new therapeutic agents.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Kirkiaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Kirkia wilmsii is a distinctive species known by a wide variety of local and descriptive names. Depending on the region, it is frequently referred to as the Bastard Pepper Tree or the Berg-Seringe. Many enthusiasts also identify the plant as Mountain Kirkia or Mountain Seringa to highlight its specific habitat. Additionally, it is commonly called the Mountain Peppertree, reflecting its physical characteristics. These diverse names all point to the same resilient and unique botanical specimen.
Sources: Catalogue of Life (COL)
Taxonomy
Kirkia wilmsii is a fascinating botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It falls specifically under the order Sapindales, showcasing its unique evolutionary lineage. The species is further organized into the genus Kirkia, which highlights its distinct morphological characteristics. Finally, it is a proud member of the family Kirkiaceae, marking its place in the complex web of life.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Kirkiaceae |
| Genus | Kirkia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Kirkia wilmsii is a notable plant species with a primary distribution spanning across the African continent. Within this vast region, it is specifically found throughout various parts of Southern Africa. Its presence is particularly documented within the borders of Eswatini, where it plays a role in the local ecosystem. Additionally, the species can be found thriving within the Northern Provinces. This widespread geographic range highlights the plant's adaptability to different environments across the southern reaches of Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Kirkia wilmsii is a self-supporting plant that exhibits a distinct tree growth form. This species can vary significantly in scale, reaching a minimum height of just 2 meters. In many environments, it develops more robustly, with typical heights ranging between 12 and 15 meters. Such structural diversity allows it to establish a firm presence within its natural habitat. Ultimately, its ability to grow as a sturdy tree makes it a notable feature of its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Kirkia wilmsii has demonstrated significant therapeutic potential through its notable antifungal and antimicrobial properties. In studies focusing on phytopathogenic fungi, the plant achieved a high mycelial growth inhibition of 50.08% against Fusarium verticillioides. Furthermore, research into its antimicrobial capabilities has highlighted the presence of bioactive agents within its leaf and twig extracts. Specifically, the isolation of catechin gallate derivatives has revealed effective antimycobacterial activity against strains such as Mycobacterium tuberculosis. These findings suggest that the plant serves as a valuable source of natural compounds for developing new medicinal treatments.
Compounds
Conditions
Kirkia wilmsii demonstrates significant antimicrobial properties against a variety of fungal and bacterial pathogens. Specifically, the extracts of this plant species are effective in treating the fungi Aspergillus fumigatus, Candida albicans, and Cryptococcus neoformans. In addition to its antifungal activity, the plant also exhibits the ability to treat the bacteria Enterococcus faecalis and Escherichia coli. These diverse inhibitory effects were identified through bioautographic screening of different solvent extracts. Consequently, the plant serves as a potent source of compounds capable of combating both these specific bacterial and fungal microorganisms.
Preparations
Kirkia wilmsii is prepared as extracts to investigate its antimicrobial properties. These preparations include leaf and twig extracts which were used to identify bioactive agents. The plant is also processed as crude extracts that can undergo solvent-solvent partitioning to increase antimycobacterial activity. Specifically, fraction 5 of twig extract was prioritized during purification due to its potent inhibitory concentration. Through these various methods, Kirkia wilmsii is prepared as plant extracts to aid in the discovery of novel medicinal derivatives.
Parts used
Kirkia wilmsii is a medicinal plant that offers significant therapeutic potential through the use of its various components. Research has specifically utilized acetone extracts derived from the plant's leaf to investigate its biological properties. These leaf extracts have demonstrated a notable ability to inhibit the mycelial growth of the phytopathogenic fungus Fusarium verticillioides. Furthermore, the chemical profiling of these extracts has led to the discovery of bioactive agents with promising antimycobacterial activity. Such findings highlight the importance of the leaf as a vital source for developing new natural treatments against various pathogens.